Navigation

SCHIZOPHRENIA

â€¹Return to Previous Page

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug (PubMed)
Cannabidiol as a potential treatment for psychosis (PubMed)
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia (PubMed)
Medical use of cannabis. Cannabidiol: A new light for schizophrenia? (PubMed)
A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation (PubMed)
Peripheral endocannabinoid system dysregulation in first-episode psychosis (PubMed)
Cannabinoids and schizophrenia: Therapeutic prospects (PubMed)
Antipsychotic-like effects of cannabidiol and rimonabant: Systematic review of animal and human studies (PubMed)
Cannabidiol monotherapy for treatment-resistant schizophrenia (PubMed)
Cannabis with high cannabidiol content is associated with fewer psychotic experiences(PubMed)
Marijuana compound treats schizophrenia with few side effects: Clinical trial (Time)
Clearing the smoke: what do we know about adolescent cannabis use and schizophrenia?(PubMed)

Mobile version: Enabled

Back to top